Serenus.AI

Company Overview

Snapshot

Founded in March 2017 by Hillary (Orly) Harel, Dan Berachowitz, and Prof. Josef Elidan, Serenus.AI operates with 1–10 employees. The company has raised $2.7 million across two funding rounds from four investors. In May 2021, Serenus.AI was granted a US patent for an automated method and system designed to screen and prevent unnecessary medical procedures.

Business overview

Serenus.AI develops advanced Generative AI technologies to enhance medical decision-making at critical points in patient pathways, aiming to optimize resource allocation and improve healthcare outcomes. Its flagship product is an AI-driven, automated case-by-case system that refines decisions before medical procedures and treatments while prioritizing patient waiting lists. The system's algorithms replicate objective decision-making processes of top physicians by integrating up-to-date medical practices, professional knowledge, and machine learning. Serenus.AI serves health systems, including US insurance companies and public health systems, operating in Europe and the United States within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support.

Strategic signal

In May 2021, Serenus.AI secured a new US patent for its automated method and system for screening and preventing unnecessary medical procedures. This patent validates the company's innovative approach to leveraging AI in healthcare, signaling its commitment to intellectual property protection and its potential to disrupt traditional medical authorization processes. For investors, this indicates a strengthened market position and a proprietary technology foundation in the competitive Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Serenus.AI's core technology?

Serenus.AI specializes in Generative AI technologies to improve medical decision-making and optimize patient pathways. Its system combines medical practices, professional knowledge, and machine learning to replicate objective decision-making processes.

When was Serenus.AI founded and by whom?

Serenus.AI was founded in March 2017 by Hillary (Orly) Harel, Dan Berachowitz, and Prof. Josef Elidan.

What significant intellectual property milestone did Serenus.AI achieve?

In May 2021, Serenus.AI was granted a new US patent for an automated method and system designed for screening and preventing unnecessary medical procedures.

Has Serenus.AI received any grants?

In July 2020, Serenus.AI received a grant from the BIRD Foundation.

Which investors participated in Serenus.AI's funding rounds?

In July 2018, Firstime VC and thetime invested in Serenus.AI's seed round.